FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323809770> ?p ?o ?g. }

• W4323809770 endingPage "1051" @default.
• W4323809770 startingPage "1046" @default.
• W4323809770 abstract "The glucagon-like peptide-1 receptor agonist dulaglutide reduced MACE in the Researching Cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) trial. This article expores the relationship of selected biomarkers to both dulaglutide and major adverse cardiovascular events (MACE).In this post hoc analysis, stored fasting baseline and 2-year plasma samples from 824 REWIND participants with MACE during follow-up and 845 matched non-MACE participants were analyzed for 2-year changes in 19 protein biomarkers. Two-year changes in 135 metabolites were also analyzed in 600 participants with MACE during follow-up and in 601 matched non-MACE participants. Linear and logistic regression models were used to identify proteins that were associated with both dulaglutide treatment and MACE. Similar models were used to identify metabolites that were associated with both dulaglutide treatment and MACE.Compared with placebo, dulaglutide was associated with a greater reduction or lesser 2-year rise from baseline in N-terminal prohormone of brain natriuretic peptide (NT-proBNP), growth differentiation factor 15 (GDF-15), high-sensitivity C-reactive protein, and a greater 2-year rise in C-peptide. Compared with placebo, dulaglutide was also associated with a greater fall from baseline in 2-hydroxybutyric acid and a greater rise in threonine (P < 0.001). Increases from baseline in two of the proteins (but neither metabolite) were associated with MACE, including NT-proBNP (OR 1.267; 95% CI 1.119, 1.435; P < 0.001) and GDF-15 (OR 1.937; 95% CI 1.424, 2.634; P < 0.001).Dulaglutide was associated with a reduced 2-year rise from baseline of NT-proBNP and GDF-15. Higher rises of these biomarkers were also associated with MACE." @default.
• W4323809770 created "2023-03-11" @default.
• W4323809770 creator A5003206993 @default.
• W4323809770 creator A5005414020 @default.
• W4323809770 creator A5014574705 @default.
• W4323809770 creator A5018263304 @default.
• W4323809770 creator A5024577116 @default.
• W4323809770 creator A5026142740 @default.
• W4323809770 creator A5030661552 @default.
• W4323809770 creator A5035968638 @default.
• W4323809770 creator A5041670111 @default.
• W4323809770 creator A5055443598 @default.
• W4323809770 creator A5065924611 @default.
• W4323809770 creator A5068892620 @default.
• W4323809770 creator A5072130761 @default.
• W4323809770 creator A5078824497 @default.
• W4323809770 date "2023-03-10" @default.
• W4323809770 modified "2023-10-18" @default.
• W4323809770 title "Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis" @default.
• W4323809770 cites W2175518135 @default.
• W4323809770 cites W2267726385 @default.
• W4323809770 cites W2333815440 @default.
• W4323809770 cites W2561702225 @default.
• W4323809770 cites W2580830941 @default.
• W4323809770 cites W2608226954 @default.
• W4323809770 cites W2621101635 @default.
• W4323809770 cites W2765222890 @default.
• W4323809770 cites W2782989965 @default.
• W4323809770 cites W2948612418 @default.
• W4323809770 cites W2996957335 @default.
• W4323809770 cites W3015012380 @default.
• W4323809770 cites W3021856094 @default.
• W4323809770 cites W3038823541 @default.
• W4323809770 cites W3088051608 @default.
• W4323809770 cites W3108967412 @default.
• W4323809770 cites W3183842190 @default.
• W4323809770 cites W3193150046 @default.
• W4323809770 cites W3195404919 @default.
• W4323809770 cites W3201242536 @default.
• W4323809770 cites W3203975425 @default.
• W4323809770 cites W3204118678 @default.
• W4323809770 cites W3214082775 @default.
• W4323809770 cites W4200183746 @default.
• W4323809770 doi "https://doi.org/10.2337/dc22-2397" @default.
• W4323809770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36897834" @default.
• W4323809770 hasPublicationYear "2023" @default.
• W4323809770 type Work @default.
• W4323809770 citedByCount "1" @default.
• W4323809770 crossrefType "journal-article" @default.
• W4323809770 hasAuthorship W4323809770A5003206993 @default.
• W4323809770 hasAuthorship W4323809770A5005414020 @default.
• W4323809770 hasAuthorship W4323809770A5014574705 @default.
• W4323809770 hasAuthorship W4323809770A5018263304 @default.
• W4323809770 hasAuthorship W4323809770A5024577116 @default.
• W4323809770 hasAuthorship W4323809770A5026142740 @default.
• W4323809770 hasAuthorship W4323809770A5030661552 @default.
• W4323809770 hasAuthorship W4323809770A5035968638 @default.
• W4323809770 hasAuthorship W4323809770A5041670111 @default.
• W4323809770 hasAuthorship W4323809770A5055443598 @default.
• W4323809770 hasAuthorship W4323809770A5065924611 @default.
• W4323809770 hasAuthorship W4323809770A5068892620 @default.
• W4323809770 hasAuthorship W4323809770A5072130761 @default.
• W4323809770 hasAuthorship W4323809770A5078824497 @default.
• W4323809770 hasBestOaLocation W43238097702 @default.
• W4323809770 hasConcept C126322002 @default.
• W4323809770 hasConcept C134018914 @default.
• W4323809770 hasConcept C142724271 @default.
• W4323809770 hasConcept C168563851 @default.
• W4323809770 hasConcept C204787440 @default.
• W4323809770 hasConcept C27081682 @default.
• W4323809770 hasConcept C2777180221 @default.
• W4323809770 hasConcept C2779829264 @default.
• W4323809770 hasConcept C2780400711 @default.
• W4323809770 hasConcept C2780533449 @default.
• W4323809770 hasConcept C2780739214 @default.
• W4323809770 hasConcept C500558357 @default.
• W4323809770 hasConcept C555293320 @default.
• W4323809770 hasConcept C67761136 @default.
• W4323809770 hasConcept C71924100 @default.
• W4323809770 hasConceptScore W4323809770C126322002 @default.
• W4323809770 hasConceptScore W4323809770C134018914 @default.
• W4323809770 hasConceptScore W4323809770C142724271 @default.
• W4323809770 hasConceptScore W4323809770C168563851 @default.
• W4323809770 hasConceptScore W4323809770C204787440 @default.
• W4323809770 hasConceptScore W4323809770C27081682 @default.
• W4323809770 hasConceptScore W4323809770C2777180221 @default.
• W4323809770 hasConceptScore W4323809770C2779829264 @default.
• W4323809770 hasConceptScore W4323809770C2780400711 @default.
• W4323809770 hasConceptScore W4323809770C2780533449 @default.
• W4323809770 hasConceptScore W4323809770C2780739214 @default.
• W4323809770 hasConceptScore W4323809770C500558357 @default.
• W4323809770 hasConceptScore W4323809770C555293320 @default.
• W4323809770 hasConceptScore W4323809770C67761136 @default.
• W4323809770 hasConceptScore W4323809770C71924100 @default.
• W4323809770 hasIssue "5" @default.
• W4323809770 hasLocation W43238097701 @default.
• W4323809770 hasLocation W43238097702 @default.
• W4323809770 hasLocation W43238097703 @default.

• next